SANTA CLARA, CA--(Marketwire - July 24, 2008) - Symyx Technologies, Inc. (NASDAQ: SMMX) announced today the launch of its new client-directed and collaborative research services for Life Sciences. These services allow clients to access Symyx’s installed base of parallel experimentation and testing capabilities through packaged offerings for solubility studies, polymorph screening, salt selection, co-crystallization, API stability in liquid and solid formulations, excipient compatibility, organic synthesis and process optimization.
